(Q48668517)

14 February 2018

title

Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons (English)

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

14 August 2023

1 reference

1 reference

F. J. White

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6145498

14 August 2023

R. Y. Wang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6145498

14 August 2023

language of work or name

English

0 references

publication date

1 May 1984

1 reference

14 February 2018

21 May 1984

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6145498

full work available at URL

14 August 2023

https://api.elsevier.com/content/article/PII:0006899384913520?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

https://api.elsevier.com/content/article/PII:0006899384913520?httpAccept=text/plain

14 August 2023

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

14 August 2023

1 reference

14 February 2018

volume

300

1 reference

14 February 2018

issue

1

1 reference

14 February 2018

page(s)

161-166

1 reference

14 February 2018

The distribution of cholecystokinin immunoreactivity in the central nervous system of the rat as determined by radioimmunoassay

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Dopamine action on hippocampal pyramidal cells

14 August 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity

14 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Increase in brain 125I-cholecystokinin (CCK) receptor binding following chronic haloperidol treatment, intracisternal 6-hydroxydopamine or ventral tegmental lesions

14 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Proglumide: selective antagonism of excitatory effects of cholecystokinin in central nervous system

14 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.

14 August 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

The actions of cholecystokinin and related peptides on pyramidal neurones of the mammalian hippocampus

14 August 2023

8

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Cholecystokinin octapeptide: Vesicular localization and calcium dependent release from rat brain in vitro

14 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Cholecystokinin peptides produce marked reduction of dopamine turnover in discrete areas in the rat brain following intraventricular injection

14 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Delayed iontophoretic ejection of substance P from glass micropipettes: Correlation with time-course of neuronal excitation in vivo

14 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Proglumide and benzotript: members of a different class of cholecystokinin receptor antagonists

14 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

The membrane potential of cat hippocampal neurons recorded in vivo displays four different reaction-mechanisms to iontophoretically applied transmitter agonists.

14 August 2023

15

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

14 August 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing

14 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Distinct cholecystokinin receptors in brain and pancreas

14 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Cholecystokinin, motilin and secretin effects on the central nervous system

14 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Effect of 6-hydroxydopamine lesions of the medial forebrain bundle on the distribution of cholecystokinin in rat forebrain.

14 August 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Dopamine modulates cholecystokinin release in neostriatum.

14 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Inhibitory effect of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius

14 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Cholecystokinin appears to have antipsychotic properties

14 August 2023

25

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

The actions of motilin, luteinizing hormone releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral cortical neurons

14 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Release of cholecystokinin peptides from a synaptosome-enriched fraction of rat cerebral cortex

14 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Cholecystokinin Receptors in the Brain: Characterization and Distribution

14 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons

14 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

An anatomy of schizophrenia?

14 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

14 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin

14 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Denervation supersensitivity to serotonin in rat forebrain: Single cell studies

14 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat

14 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

14 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Studies on the pharmacology of neurones in the nucleus accumbens of the rat

14 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Response of nucleus accumbens neurons to amygdala stimulation and its modification by dopamine

14 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

Autoradiographic localization of cholecystokinin receptors in rodent brain

14 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0006-8993(84)91352-0

14 August 2023

Identifiers

1 reference

14 February 2018

1 reference

14 February 2018